Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54252-2 Glucose^2M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54252-2         Observation       0 Glucose 2M p Gc SerPl-sCnc       N   2M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54253-0 Glucose^4M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --4 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54253-0         Observation       0 Glucose 4M p Gc SerPl-sCnc       N   4M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54254-8 Glucose^5M pre dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --5 minutes pre dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54254-8         Observation       0 Glucose 5M pre Gc SerPl-sCnc       N   5M pre Gc; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; Pl; Plasma; Plsm; Point in time; pre Gc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54255-5 Glucose^6M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --6 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54255-5         Observation       0 Glucose 6M p Gc SerPl-sCnc       N   6M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54256-3 Glucose^8M post dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --8 minutes post dose glucagon   MIN DefinitionDescription     mmol/L             CHAL   54256-3         Observation       0 Glucose 8M p Gc SerPl-sCnc       N   8M p Gc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HGF; Hyperglycemic factor; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54257-1 Glucose^pre dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --pre dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54257-1         Observation       0 Glucose pre Ins IV SerPl-sCnc       N   Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54258-9 Glucose^2H post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2 hours post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54258-9         Observation       0 Glucose 2h p Ins IV SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54259-7 Glucose^2.5H post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2.5 hours post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54259-7         Observation       0 Glucose 2.5h p Ins IV SerPl-sCnc       N   2.5h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
5426-2 CD11a ACnc WBC Pt Qn     DEPRECATED Deprecated CD11a cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5426-2                 0 Deprecated CD11a WBC-aCnc           AlphaL integrin chain; Arbitrary concentration; CELL MARKERS; Leukocytes; LFA-1alpha; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54260-5 Glucose^15M post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54260-5         Observation       0 Glucose 15M p Ins IV SerPl-sCnc       N   15M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54261-3 Glucose^15M pre dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54261-3         Observation       0 Glucose 15M pre Ins IV SerPl-sCnc       N   15M pre Ins IV; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54262-1 Glucose^3H pre dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --3 hours pre dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54262-1         Observation       0 Glucose 3h pre Ins IV SerPl-sCnc       N   3h pre Ins IV; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; pre Ins IV; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54263-9 Glucose^30M post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54263-9         Observation       0 Glucose 30M p Ins IV SerPl-sCnc       N   30M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54264-7 Glucose^45M post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --45 minutes post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54264-7         Observation       0 Glucose 45M p Ins IV SerPl-sCnc       N   45M p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54265-4 Glucose^1H post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1 hour post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54265-4         Observation       0 Glucose 1h p Ins IV SerPl-sCnc       N   1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54266-2 Glucose^1.3H post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54266-2         Observation       0 Glucose 1.3h p Ins IV SerPl-sCnc       N   1.3h p Ins IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54267-0 Glucose^1.5H post dose insulin IV SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose insulin IV   MIN DefinitionDescription     mmol/L             CHAL   54267-0         Observation       0 Glucose 1.5h p Ins IV SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.7 2.27               mmol/L       0
54268-8 Glucose^pre dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --pre dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54268-8         Observation       0 Glucose pre OKG SerPl-sCnc       N   2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; AKG; Alfa; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; Pl; Plasma; Plsm; Point in time; pre OKG; pre Orn; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54269-6 Glucose^2H post dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2 hour post dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54269-6         Observation       0 Glucose 2h p OKG SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p OKG; 2h p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
5427-0 CD11b ACnc WBC Pt Qn     DEPRECATED Deprecated CD11b cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5427-0                 0 Deprecated CD11b WBC-aCnc           AlphaM integrin chain; AlphaM-beta2; Arbitrary concentration; C3biR; CELL MARKERS; CR3; Leu15; Leu-15; Leukocytes; Mac-1; Mo1; Point in time; QNT; Quan; Quant; Quantitative; R3; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54270-4 Glucose^2.5H post dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2.5 hour post dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54270-4         Observation       0 Glucose 2.5h p OKG SerPl-sCnc       N   2.5h p OKG; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54271-2 Glucose^15M post dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes post dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54271-2         Observation       0 Glucose 15M p OKG SerPl-sCnc       N   15M p OKG; 15M p Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54272-0 Glucose^15M pre dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --15 minutes pre dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54272-0         Observation       0 Glucose 15M pre OKG SerPl-sCnc       N   15M pre OKG; 15M pre Orn; 2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; AKG; Alfa; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; Pl; Plasma; Plsm; Point in time; pre OKG; pre Orn; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54273-8 Glucose^3H post dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --3 hours post dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54273-8         Observation       0 Glucose 3h p OKG SerPl-sCnc       N   2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 3h p OKG; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
54274-6 Glucose^30M post dose ornithine alpha-ketoglutarate SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose ornithine alpha-ketoglutarate   MIN DefinitionDescription     mmol/L             CHAL   54274-6         Observation       0 Glucose 30M p OKG SerPl-sCnc       N   2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 30M p OKG; 30M p Orn; After; AKG; Alfa; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; OKG; Orn; Ornicetil; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.27               mmol/L       0
104,672 results found